Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
121
-
122
CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).
Published 2024“…<p>CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).</p>…”
-
123
-
124
-
125
-
126
Decreased MBP levels in the brain in <i>Large</i><sup><i>myd/myd</i></sup> mice.
Published 2020“…The results are presented as the mean of at least three experiments. <b>B,</b> Whole-brain lysates of P7 control and <i>Large</i><sup><i>myd/myd</i></sup> mice (<i>n</i> = 5) were obtained for MBP immunoblotting. …”
-
127
-
128
-
129
The mean and standard deviation of parameters.
Published 2024“…Additionally, one-way ANCOVA revealed a significant difference between the groups post-treatment (F(1,31) = 6.011, P = 0.020, η2 = 0.162) and one month post-treatment (F(1,31) = 4.889, P = 0.035, η2 = 0.136), with ML SI being significantly lower in the exergaming group than the balance training group at both time points. …”
-
130
Results for K<sub>s</sub>/D = 8.8 × 10<sup>−5</sup>, (a) Power, (b) Frequency, and (c) Amplitude.
Published 2025Subjects: -
131
Results for K<sub>s</sub>/D = 5.08 × 10<sup>−4</sup>, (a) Power, (b) Frequency, and (c) Amplitude.
Published 2025Subjects: -
132
-
133
-
134
-
135
-
136
Annual number of outpatient visits in all eyes.
Published 2025“…In the recurrence group, BCVA (logMAR) showed no significant improvement over time: 0.37 ± 0.20 preoperatively and 0.35 ± 0.23, 0.35 ± 0.18, 0.31 ± 0.23, 0.34 ± 0.26, 0.28 ± 0.30, and 0.24 ± 0.23 at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p = 0.45). In contrast, the non-recurrence group demonstrated significant and sustained improvement from 0.31 ± 0.25 preoperatively to 0.25 ± 0.25, 0.23 ± 0.26, 0.23 ± 0.28, 0.21 ± 0.27, 0.20 ± 0.30, and 0.16 ± 0.30 at corresponding postoperative time points (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g005" target="_blank">Fig 5</a>).…”
-
137
-
138
-
139
-
140